Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision‐Making

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 studyEarly-Phase Clinical Trial · 2018 · 62 citations
2. 2Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyPrognostic Study · 2016 · 46 citations
3. 3Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsPrognostic Study · 1983 · 439 citations
4. 4Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysisMeta-Analysis · 2020 · 31 citations
5. 5The outcomes of second haploidentical donor transplantation for graft failure in patients with severe aplastic anaemiaCohort Study · 2025 · 2 citations